PortViewPortView
Brooks Automation logo

Brooks Automation (BRKS) Stock Analysis

NASDAQTechnologySemiconductors

$113.10-2.73%
1-year price historyRange $112.61 – $124.15
52-week range$113.10
$65.37$124.79

Track BRKS in your portfolio for free · Portfolio tracker

What Brooks Automation does

Brooks Automation, Inc. (BRKS), founded in 1978 and headquartered in Chelmsford, Massachusetts, stands as a global leader in delivering advanced automation and cryogenic technologies to clients in approximately 50 countries. The company operates through two distinct divisions: the Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group is dedicated to the semiconductor capital equipment sector, offering sophisticated wafer automation and contamination control solutions alongside a full suite of support services. This segment's product range encompasses a variety of atmospheric and vacuum robots, robotic modules, and comprehensive tool automation systems, all designed to ensure precise handling and maintain pristine conditions within wafer environments. They also provide automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. Beyond products, this group offers crucial services including repairs, diagnostics, installations, spare parts, and productivity-boosting upgrades. The Brooks Life Science Systems division caters to the intricate demands of the life sciences sample management market. It supplies automated cold storage systems and an extensive array of consumables, such as various formats of racks, tubes, caps, plates, and foils. Additionally, the segment manufactures specialized instruments for laboratory tasks like labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. Its comprehensive service offerings span complete sample management, including both on-site and off-site storage, meticulous cold chain logistics, secure sample transport and relocation, bio-processing solutions, disaster recovery, and business continuity planning, complemented by expert project management and consulting. This division further develops advanced sample intelligence software, facilitates customer technology integration, and provides solutions for optimizing laboratory workflow scheduling, managing sample inventory and logistics, monitoring environmental conditions, overseeing clinical trials and consent, as well as offering planning, data management, virtualization, and visualization services. Moreover, it delivers gene sequencing analysis and synthesis capabilities.

Key metrics

Market cap
$7.82B
P/E (TTM)
0.00
EPS (TTM)
$0.00
Beta
1.77
Dividend yield
0.00%
Revenue / share
$13.55
50-day avg
$110.97
200-day avg
$96.38
52-week high
$124.79
52-week low
$65.37
CEO
Stephen Schwartz

ETFs linked to BRKS

Broad-market and Technology sector ETFs an investor holding Brooks Automation is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BRKS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BRKS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Brooks Automation?
Brooks Automation trades under the ticker BRKS on NASDAQ.
Which exchange is BRKS listed on?
BRKS is listed on NASDAQ.
What sector does Brooks Automation operate in?
Brooks Automation is classified in the Technology sector (Semiconductors industry).
How can PortView help analyze BRKS in a portfolio?
PortView shows BRKS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.